Dr Helen Groves is a clinical lecturer in paediatric infectious diseases. Dr Groves trained in the UK postgraduate Clinical Academic Training Program, completing both Academic Clinical Fellowship and Academic Clinical Lectureship positions at Queen’s University Belfast as well as a Wellcome Trust funded PhD Fellowship in early life development of airway epithelial cell innate immune responses to respiratory syncytial virus infection. Dr Groves completed her clinical training in infectious diseases as part of the UK Paediatric Infectious Diseases subspecialty training program as well as undertaking a Clinical Fellowship in Paediatric Infectious Diseases at the Hospital for Sick Children, Toronto between 2019 and 2021.

Dr Groves’s overarching research interest is early-life respiratory viral infections with the goal of increasing understanding of respiratory virus driven immune responses in children and developing future treatment interventions. Dr Groves is involved in a number of ongoing projects in this area.  She is currently a co-investigator on the large pan-European, Canadian and US multi-centre CAR-CF trial which aims to characterise antibody responses to COVID-19 in children and adults with cystic fibrosis.  Dr Groves is lead investigator of the INHALER study, a cohort study examining the impact of the COVID-19 pandemic on subsequent viral-wheeze and asthma development in young children. Dr Groves is also co-lead investigator on the PRECISE study, which aims to investigate the role of point-of-care respiratory virus testing to direct corticosteroid use in preschool aged children with acute wheeze.